Is Caris Life Sciences (CAI) Pricing Look Attractive After Recent Share Price Pullback [Yahoo! Finance]
Caris Life Sciences, Inc. (CAI)
Last caris life sciences, inc. earnings: 10/29 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.capps.com/investor-relations
Company Research
Source: Yahoo! Finance
If you are wondering whether Caris Life Sciences at around US$18.31 is starting to look interesting on price, the key question is how its current market value stacks up against its fundamentals. The stock has recently been under pressure, with returns of a 12.2% decline over 7 days, a 29.6% decline over 30 days and a 32.1% decline year to date, which may have shifted how some investors think about its risk and potential reward. Recent news coverage around Caris Life Sciences has focused on its position in the pharmaceuticals and biotech space and investor interest in precision medicine, giving context to the sharp pullback in the share price. While headlines can move sentiment quickly, they do not always line up with a careful assessment of what the business may be worth. Right now, Caris Life Sciences scores a valuation rating of 4 out of 6 , based on checks of whether the stock looks undervalued on several metrics. The sections that follow will walk through the main valuation
Show less
Read more
Impact Snapshot
Event Time:
CAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAI alerts
High impacting Caris Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
CAI
News
- Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer [Yahoo! Finance]Yahoo! Finance
- Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic CancerPR Newswire
- Caris Life Sciences (CAI) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CAI&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
- Assessing Caris Life Sciences (CAI) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Caris Life Sciences Inc (CAI) Q4 2025 Earnings Call Highlights: Record Revenue Surge and ... [Yahoo! Finance]Yahoo! Finance
CAI
Earnings
- 2/26/26 - Beat
CAI
Sec Filings
- 3/3/26 - Form 10-K
- 3/2/26 - Form 4
- 2/27/26 - Form 4
- CAI's page on the SEC website